Role of the Immune Environment in Response to Therapy in Breast Cancer
Status
Enrolling
Conditions
Breast Cancer
TNBC - Triple-Negative Breast Cancer
ER Positive Breast Cancer
HER2-negative Breast Cancer
Treatments
Other: Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.
Details and patient eligibility
About
This is an observational case-control study of tissues collected from women with ER+HER2- breast cancers. The immune environments of these cancers will be compared to triple negative and HER2+ breast cancers. No randomization or changes to standard of care treatment will occur as part of the study.
Enrollment
300 estimated patients
Sex
Female
Ages
18+ years old
Volunteers
No Healthy Volunteers
Inclusion criteria
Women 18 years of age or older with non-metastatic breast cancer undergoing surgical resection in the University of Pennsylvania Health System.
Exclusion criteria
Males Children Pregnant individuals
Trial contacts and locations
1
Loading...
Central trial contact
Julia T. Lewandowski; Jennifer Zhang, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems